(Q33483399)

27 July 2017

title

Platelet loss during experimental cardiopulmonary bypass and its prevention with prostacyclin (English)

1 reference

27 July 2017

Plachetka JR

1

1 reference

27 July 2017

Salomon NW

series ordinal

2

1 reference

27 July 2017

Larson DF

series ordinal

3

1 reference

27 July 2017

Copeland JG

series ordinal

4

1 reference

27 July 2017

language of work or name

English

0 references

publication date

1 July 1980

1 reference

The Annals of Thoracic Surgery

27 July 2017

published in

1 reference

27 July 2017

volume

30

1 reference

27 July 2017

issue

1

1 reference

27 July 2017

page(s)

58-63

1 reference

Preservation of human platelets with prostaglandin E1 during in vitro simulation of cardiopulmonary bypass

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2810%2961203-9

Pooling of platelets in the spleen: role in the pathogenesis of "hypersplenic" thrombocytopenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2810%2961203-9

Morphology and enumeration of human blood platelets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2810%2961203-9

Modulation of human platelet adenylate cyclase by prostacyclin (PGX)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2810%2961203-9

De-aggregatory action of prostacyclin and its enhancement by theophylline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2810%2961203-9

Generation of prostacyclin by lungs in vivo and its release into the arterial circulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2810%2961203-9

Reversal of platelet aggregation by prostacyclin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2810%2961203-9

Lungs as a generator of prostacyclin — Hypothesis on physiological significance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2810%2961203-9

Anti-platelet action of intravenous infusion of prostacyclin in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2810%2961203-9

Prostacyclin: a solution to some problems of extracorporeal circulation. Experiments in greyhounds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2810%2961203-9

Prostacyclin is a circulating hormone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2810%2961203-9

Unstable metabolites of arachidonic acid and their role in haemostasis and thrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2810%2961203-9

A study of platelet counts during cardiopulmonary bypass

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2810%2961203-9

BLOOD PLATELETS AND EXTRACORPOREAL CIRCULATION

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2810%2961203-9

Effects of prostacyclin (PGX) on cyclic AMP concentrations in human platelets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2810%2961203-9

Prostacyclin can replace heparin in haemodialysis in dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2810%2961203-9

10.1016/S0003-4975(10)61203-9

7 January 2021

Identifiers

DOI

1 reference

27 July 2017

1 reference